BioElectron Technology is advancing EPI-743, a pre-NDA stage compound for the treatment of inherited mitochondrial disease as well as EPI-589, being developed for the treatment of adult neurodegenerative diseases.
Company (Alive / Active)
350 North Bernardo Ave
Mountain View, 94043
California, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)